Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTEA.L Regulatory News (CTEA)

  • There is currently no data for CTEA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Catenae Innovation Plc: Placing, Appointment of Joint Broker, Issue of Warrants and Related Party Transaction

27 Feb 2019 07:00



Catenae Innovation Plc: Placing, Appointment of Joint Broker, Issue of Warrants and Related Party Transaction

CATENAE INNOVATION PLC

("Catenae" or the "Company")

Placing, Appointment of Joint Broker,Issue of Warrants and Related Party Transaction

Catenae (AIM: CTEA), the AIM-quoted provider of digital media and technology, is pleased to announce a placing and subscription for a total of 575,000,000 new ordinary shares of 0.10 pence per share in the Company at a price of 0.10 pence per share (“Placing Shares”) for gross proceeds of £575,000 (“the Placing”).

The Placing Shares have been issued at the prevailing market mid-price and the Placing includes further investment from an existing institutional investor to maintain its percentage holding.

Certain directors and senior managers have participated in the Placing, which is a related party transaction, further details of which is set out below.

Issue of Warrants

The Company is also issuing one warrant for every one Placing Share issued at an exercise price of 0.125p which may be exercised up to three years from the date of issue. If exercised, the warrant holder will be entitled to receive a further warrant exercisable at 0.15p which may be exercised for a further two-year period (together, the "Placing Warrants").

The Placing Warrants will not be listed and will be part-issued (approximately 50 per cent.) on Admission of the Placing Shares and part subject to approval of authorities being granted at an Extraordinary General Meeting, notice of which is provided supplementary to this statement.

Appointment of Joint Broker

The Company is pleased to announce that Turner Pope Investments Limited (“TPI”) has been appointed Joint Broker with immediate effect.

The Placing was undertaken by TPI which has agreed to receive the majority of their broking fee in shares at the Placing Price and, accordingly, a further 20,000,000 ordinary shares (“Fee Shares”) will be issued.

Admission

Application will be made for the 595,000,000 new ordinary shares to be admitted to trading on AIM, which is expected to occur on or around 5 March 2019. The 595,000,000 new ordinary shares will rank pari passu with the existing ordinary shares of Catenae.

Following Admission of the Placing Shares and Fee Shares, the Company will have in issue 3,173,601,652 ordinary shares with voting rights. The Company holds 83,333,332 ordinary shares in treasury. The above figure of 3,173,601,652 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Related Party Transaction

NameTitleNumber of shares subscribed for in the PlacingNumber of ordinary shares held following the Placing
Tony SandersDirector75,000,000107,287,499
Guy MeyerDirector15,000,000110,458,292
Alan SimpsonChief Technology Officer10,000,00026,667,667
John FarthingChief Financial Officer10,000,00018,333,334
Total 110,000,000262,746,792

The issue of shares to Tony Sanders, Guy Meyer, Alan Simpson and John Farthing is a related party transaction pursuant to AIM Rule 13 (the “Transaction”). Kevin Everett, a director of the Company who is independent of the Transaction, having consulted with Cairn Financial Advisers LLP, the Company's nominated adviser, believes that the terms of the transaction are fair and reasonable insofar as shareholders are concerned.

Tony Sanders – CEO“We are pleased to receive this additional support at an important time for the Company’s development strategy and Catenae will invest a substantial proportion of the Placing funds in sales and marketing initiatives to help secure existing opportunities and develop the sales pipeline.”

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014. The person who arranged for release of this announcement on behalf of the Company was Tony Sanders (Chief Executive Officer).

For further information:

Catenae Innovation PlcTony SandersTel: 020 7929 7826
Cairn Financial Advisers LLP, Nominated AdviserLiam Murray / Jo Turner Tel: 020 7213 0880
Alexander David Securities Limited, Joint BrokerDavid Scott / James DewhurstTel: 020 7448 9820
Turner Pope Investments Limited, Joint BrokerAndy ThackerTel: 020 3621 4120
  

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014
1Details of the person discharging managerial responsibilities/person closely associated
a.Name Tony SandersGuy MeyerAlan SimpsonJohn Farthing
2Reason for notification 
a.Position/Status DirectorDirectorChief Technology OfficerChief Financial Officer
b.Initial notification/AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a.NameCatenae Innovation plc
b.LEI2138007I2D8YWPMSP544
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a.Description of the financial instrument, type of instrument Identification Code Ordinary shares of 0.10 pence per share ISIN: GB0033127910
b.Nature of the transaction Issue of shares in the Placing
c.Price(s) and volume(s)     
 Price(s) per shareVolume(s) 
0.10pa) 75,000,000b) 15,000,000c) 10,000,000d) 10,000,000 
 
d.Aggregated information - Aggregated Volume - Price 110,000,000 0.10p
e.Date of the transaction27 February 2019
f.Place of the transactionAIM, London Stock Exchange


Date   Source Headline
1st Jul 20203:12 pmRNSTotal Voting Rights
1st Jul 20202:06 pmRNSSecond Price Monitoring Extn
1st Jul 20202:00 pmRNSPrice Monitoring Extension
1st Jul 20207:00 amRNSCompletion of Cov-ID Project
30th Jun 20207:01 amRNSHalf-year Report
30th Jun 20207:00 amRNSFinal Results
26th Jun 20204:30 pmRNSExercise of Warrant
23rd Jun 20204:41 pmRNSSecond Price Monitoring Extn
23rd Jun 20204:36 pmRNSPrice Monitoring Extension
19th Jun 20207:00 amRNSCov-ID Project Update
12th Jun 20209:58 amRNSIssue of Equity
11th Jun 20202:02 pmRNSShare Price Movement and Update
10th Jun 202012:30 pmRNSExercise of Warrant, Conversion & Issue of Equity
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
3rd Jun 20207:00 amRNSHolding(s) in Company
29th May 202012:24 pmRNSHolding(s) in Company
29th May 20207:00 amRNSAgreement with Newcastle Premier Health Ltd
28th May 20204:41 pmRNSSecond Price Monitoring Extn
28th May 20204:35 pmRNSPrice Monitoring Extension
21st May 20207:00 amRNSExercise of Warrant and Issue of Equity
18th May 20207:00 amRNSCov-ID Project Update
14th May 202012:49 pmRNSResult of General Meeting and Issue of Equity
1st May 20209:00 amRNSUpdate - Cov-ID Project
29th Apr 20205:09 pmRNSPosting of Circular and Notice of General Meeting
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSDirectorate Changes
23rd Apr 202012:19 pmRNSHolding(s) in Company
21st Apr 20202:05 pmRNSSecond Price Monitoring Extn
21st Apr 20202:00 pmRNSPrice Monitoring Extension
20th Apr 20203:32 pmRNSConditional Placing to raise £320,000 and Update
17th Apr 20207:00 amRNSCatenae joins Consortium on Cov-ID Project
16th Apr 20205:30 pmRNSChange of Broker
31st Mar 20202:45 pmRNSHolding(s) in Company
31st Mar 20202:40 pmRNSHolding(s) in Company
31st Mar 20202:35 pmRNSHolding(s) in Company
31st Mar 20207:00 amRNSAnnual Report, Trading & COVID-19 Update
26th Mar 202012:49 pmRNSWorking Capital Facility
31st Jan 20201:36 pmRNSIssue of Equity & Proposed Directorate Change
24th Jan 20201:20 pmRNSUpdate re Working Capital & Balance Sheet
10th Jan 202012:23 pmRNSUpdate re Working Capital & Balance Sheet
23rd Dec 201911:37 amRNSResult of General Meeting
20th Dec 20195:02 pmRNSUpdate re Working Capital
20th Dec 20191:23 pmRNSFurther re Share Capital & Timetable Update
20th Dec 20197:00 amRNSShare Capital and Total Voting Rights
19th Dec 20197:00 amRNSFurther re Agreements and update
6th Dec 201910:53 amRNSPosting of Circular and Notice of General Meeting
12th Sep 201910:50 amRNSHolding(s) in Company
11th Sep 20197:30 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.